Invention is an essential feature of business. The best inventions are created when you mix talented people playing to their strengths in an environment of open collaboration, working in partnership with clients and suppliers with a clear focus on commercial goals.
Exciting and varied work that makes a difference. A collaborative culture where you can take on complex technical challenges and deliver commercial impact. That's life at TTP.
The use of artificial intelligence (AI) to aid medical diagnosis or rationalise healthcare raises similar ethical challenges as applications of AI in other industries, bias and discrimination among them. A prescription of selective forgetfulness for the AI may be a remedy, argue Roderick van den Bergh and Desmond Cheung.
Some very common medical conditions like migraine have evaded diagnosis and treatment until now. We explore why Machine Learning might finally be the tool to tame migraines but why it is still not an easy path to a successful product.
Antimicrobial susceptibility testing at the point of care could slow the spread of antimicrobial resistance, but only creative technology development and regulatory equivalence data will unlock this prize.
Recent industry deals show what automotive lidar companies need to win an OEM order: a credible path to low-cost, compact products. The sensor optics and unconventional optical designs can offer that much-needed edge over competitors, says Alex Coney.
Until we start to feel the impact of the vaccine rollout, we need to develop safe, reliable and rapid mechanisms which could allow schools to stay open and stop important sections of the economy, such as the hospitality sector, from having to close their doors completely again. That’s where our focus has been.
TTP is exhibiting at CES 2021, 11-14 January 2021
Sam Hyde shares his views with Red Box for The Times.
TTP consultant, Douglas Bradsahw, was interviewed on Sky News, Ian King Live and discussed CoTest™, TTP's new COVID-19 screening technology to to be used by anyone, anywhere, to screen up to 40 people at once for Covid-19 with results available in 30 minutes.
